# Epilepsy Incidence Among Children in the United States

Source: https://welltoldgrants.com/grants/rfa-dp-25-038-epilepsy-incidence-among-children-in-the-united-states/  
Official notice: https://www.grants.gov/search-results-detail/355205

> Centers for Disease Control and Prevention - ERA offered grants of up to $500,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make one award worth $1.6 million in total. Applications closed on January 23, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-DP-25-038 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | January 23, 2025 |
| Award ceiling | $500,000 |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $1.6 million |
| Cost sharing | not required |
| Assistance Listings | 93.068 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses

N/A

## What the grant funds

Few population-based epilepsy incidence studies among children in the United States exist, and these studies are limited to specific geographic areas with small sample sizes. Studies which used nationwide administrative and claims data to estimate epilepsy incidence among children were conducted more than a decade ago and failed to provide national generalizability due to their limited data sources. This NOFO will contribute to a comprehensive understanding of epilepsy incidence (any type), incident-related risk factors, and incidence disparities among the general U.S. pediatric population or subpopulations. The knowledge obtained from this study will assist health officials shape public health policies by allocating resources, planning for healthcare services, and implementing preventive measures. The objectives of the NOFO are to: (1) Estimate epilepsy incidence among U.S. children 0 - 17 years of age based upon a study with comprehensive nationwide dataset(s), or a population-based study at a specific level(s) (e.g., national, regional, jurisdictional); (2) Identify factors that contribute to the risk of developing epilepsy, and examine the association between these risk factors and incidence; and (3) Examine potential disparities in incidence rates of epilepsy stratified by demographic, geographical, the social determinants of health (SDOH), or other characteristics. The target population is for U.S. children aged 0 - 17 years, and for the study of certain epilepsies, some age ranges within 0 - 17 years are acceptable. Additionally, this study should include a nationally representative sample of age, sex, race/ethnicity, and social strata, and include subgroups which allow an examination of risk factors and SDOH. The applicant is expected to: (1) Conduct a retrospective study using public/commercial administrative and/or claims data, electronic health records, or survey data; (2) Ensure dataset(s) have sufficient sample sizes relative to risk factors, allowing incidence rates to be stratified by these factors. If public/commercial claims data or survey data are used, it should include child populations from all states and Washington DC. Examples of claims data are Marketscan and Medicaid. If EHR data are used, adequate details/justification must be included; (3) Identify risk factors based on the literature.

## Questions people ask

### Is RFA-DP-25-038 still open?

No. It closed on January 23, 2025. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Epilepsy Incidence Among Children in the United States?

Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Epilepsy Incidence Among Children in the United States?

Closed January 23, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $500,000 each. About $1.6 million in total for one award.

### Who has won Chronic Diseases:  Research, Control, and Prevention   grants before?

The largest recipients over five fiscal years were New York University, American College of Rheumatology, Inc, Lupus Foundation of America Inc. The program made 88 awards worth $57.3 million in that time.